Mr. Ilan Sobel reports

BIOHARVEST SCIENCES TO HOST VIRTUAL SHAREHOLDER UPDATE DECEMBER 13, 2023, 2:30PM ET

Bioharvest Sciences Inc. will host a Q3 performance update presentation on Wednesday, Dec. 13, 2023, at 11:30 a.m. PST (2:30 p.m. EST). The interactive session will be hosted by Ilan Sobel, chief executive officer of Bioharvest Sciences.

"I am currently in Nashville, Tenn., as part of a U.S. media and operational partner tour ahead of the imminent launch of our Vinia functional coffee, and I am energized by the positive and committed feedback I am receiving as I meet with our marketing, commercial and investor partners," stated chief executive officer Ilan Sobel. He added "As announced in our Q3 financials this week, we have achieved double-digit revenue growth quarter over quarter, we have improved our gross profit margins, and we are actively planning the launches of disruptive new products. I look forward to hosting the Dec. 13 shareholder update and to answering questions from several hundred of our energized shareholder partners while enjoying a fresh mug of our delicious new Vinia coffee."

Mr. Sobel will discuss the Q3 2023 financials announced Nov. 29, 2023, and he will provide additional information regarding the Vinia coffee launch and other major Vinia marketing programs and coming new product pipeline. Following the presentation, there will be a live question-and-answer session. All media and investors are invited to preregister. For any questions regarding the event, please contact info@bioharvest.com.

Q3 corporate highlights released Nov. 29, 2023:

• Q3 Vinia revenues of $3.24-million (U.S.) represent growth of 113 per cent compared with Q3 2022 and an 18-per-cent increase compared with Q2 2023;
• Year-over-year Q3 gross profit improved from 18 per cent to 45 per cent;
• Q4 2023 revenue range guidance of $4.2-million (U.S.) to $4.5-million (U.S.);
• Vinia total active subscriber count grew by 213 per cent year over year.

About Bioharvest Sciences Inc.

Bioharvest Sciences is a fast-growing biotechnology firm listed on the Canadian Securities Exchange. Bioharvest has developed a patented biocell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at an industrial scale, without the need to grow the plant itself. Bioharvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions, within two major business verticals -- nutraceutical health and wellness products such as dietary supplements; and development of plant-cell-based active pharmaceutical ingredients (APIs) that focus on specific medical indications.

We seek Safe Harbor.